TE
CTMX icon

Tema ETFs’s CytomX Therapeutics CTMX Stock Holding History

Tema ETFs’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859K Buy
228,987
+1,482
+0.7% +$5.66K 0.03% 319
2026
Q1 		$1.07M Buy
+227,505
New +$1.15M 0.07% 229

Other funds holding CTMX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Tema ETFs's CTMX Position: Q2 2026 in Review

Tema ETFs increased its CytomX Therapeutics (CTMX) stake by 0.65% in Q2 2026, buying an estimated $5.66K and bringing the position to 228,987 shares worth $859K. The position accounts for 0.03% of the portfolio, ranked #319.

Tema ETFs first reported a position in CTMX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.07M in Q1 2026. 7 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Tema ETFs held 228,987 shares of CytomX Therapeutics worth $859K as of Q2 2026.
  • Tema ETFs bought 1,482 CytomX Therapeutics shares in Q2 2026, an estimated $5.66K.
  • CytomX Therapeutics made up 0.03% of Tema ETFs's portfolio in Q2 2026, its #319 holding.
  • Tema ETFs first reported a position in CytomX Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Tema ETFs's CytomX Therapeutics position peaked at $1.07M in Q1 2026.
  • 7 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.